Europe Diabetes Care Devices Market (2025-2030)
The Europe Diabetes Care Devices Market was valued at $10622.8 Million in 2025 and projected to reach to $17731.6 Million by 2030, representing a compound annual growth rate of 10.8%. Europe's diabetes care devices market is positioned for sustained expansion through 2030, driven by demographic shifts, rising disease prevalence, and substantial healthcare spending.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe Diabetes Care Devices Market Trends and Insights
- This expansion reflects Europe's aging population, rising diabetes prevalence, and increasing healthcare investments across the region.
- Europe is witnessing accelerated adoption of advanced glucose monitoring systems, insulin delivery devices, and connected diabetes management solutions driven by regulatory support and reimbursement improvements. The European market benefits from strong healthcare infrastructure, high awareness of diabetes management, and favorable government policies promoting preventive care.
- Europe's emphasis on digital health integration and patient-centric solutions is reshaping the competitive landscape.
- Between 2025 and 2030, Europe is expected to see significant innovation in continuous glucose monitoring (CGM) devices and automated insulin delivery systems, supported by increasing collaboration between medical device manufacturers and healthcare providers across the continent..
Key Market Statistics
- CAGR (2025-2030) 10.8% CAGR
- Market Size, 2025 ~USD 10622.8 Million
- Forecast, 2030 ~USD 17731.6 Million
- Geography Europe
Europe Diabetes Care Devices Market Overview
Market Valuation & Growth :
Europe's diabetes care devices market is valued at $10,622.8 million in 2025, with a projected CAGR of 10.8% through 2030, reaching $17,731.6 million. This growth outpaces many global regions due to strong healthcare infrastructure and regulatory support.
Aging Population Driving Demand :
Europe's rapidly aging demographic is a primary growth catalyst, with increasing diabetes prevalence among elderly populations. Rising healthcare investments across EU member states are accelerating adoption of advanced monitoring and insulin delivery technologies.
Advanced Technology Adoption :
European markets are witnessing accelerated adoption of continuous glucose monitoring (CGM) systems, insulin pumps, and connected diabetes management devices. Strong reimbursement policies and digital health initiatives support rapid technology penetration across the region.
Regional Market Leadership :
Germany leads European market with $4,763.8 million, followed by France ($2,504 million) and Italy ($1,888.8 million). These markets benefit from robust healthcare systems, high patient awareness, and favorable regulatory environments for innovative diabetes solutions.
Europe Diabetes Care Devices Market Dynamics
- The region's mature healthcare infrastructure and strong regulatory frameworks create favorable conditions for innovation and market penetration of advanced glucose monitoring and insulin delivery systems.
- Digital health integration and reimbursement support further accelerate adoption rates across major European markets. Key growth drivers include increasing patient awareness, physician adoption of advanced technologies, and government initiatives promoting preventive care.
- European markets benefit from established distribution networks and strong healthcare provider relationships.
- The competitive landscape remains dynamic, with both established medical device manufacturers and emerging innovators investing heavily in European market expansion, particularly in CGM systems and connected diabetes management platforms..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Europe's diabetes care devices market will grow from $10.6B (2025) to $17.7B (2030) at a 10.8% CAGR, driven by aging demographics and rising diabetes incidence across the region.
- Europe is leading in CGM adoption and digital diabetes management solutions, with strong regulatory frameworks supporting innovation and market expansion.
- Reimbursement improvements and government healthcare initiatives in Europe are accelerating patient access to advanced diabetes care devices.
- Europe's competitive landscape is intensifying as manufacturers invest in connected devices and AI-enabled solutions to meet evolving patient and healthcare provider needs.
Diabetes Care Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | DIABETES MANAGEMENT MOBILE APPLICATIONS (Product Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 12.3% from 2025 to 2030 |
| Largest Segment | TYPE 2 DIABETES (Disease Type) |
| Market Size Base Year (Billions) | ~USD 34.27 (2025) |
| Revenue Forecast (Billions) | ~USD 61.2 (2030) |
| Segments Covered | Product Type, Type, Disease Type, Patient Care Settings |
Europe Diabetes Care Devices Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product Type
- Blood Glucose Monitoring System
- Blood Glucose Monitoring Systems
- Diabetes Management Mobile Applications
- Insulin Delivery Devices
By Type
- Continuous Glucose Monitoring Systems
- Disposable Insulin Pens
- Insulin Pens
- Insulin Pumps & Accessories
- Insulin Syringes & Needles
- Lancets/Lancing Devices
- Other Insulin Delivery Devices
- Pen Needles
- Reusable Insulin Pens
- Self-Monitoring Blood Glucose Systems
- Test Strips/ Test Papers
- Test Strips/Test Papers
- Tethered Insulin Pumps
- Tubeless Insulin Pumps
By Disease Type
- Type 1 Diabetes
- Type 2 Diabetes
By Patient Care Settings
- Hospitals & Diabetes Specialty Clinics
- Self/ Home Healthcare
- Self/Home Healthcare
Target Audience
- Medical Device Manufacturers : Manufacturers need detailed European market data to guide product development, market entry strategies, and competitive positioning. Country-specific insights enable targeted go-to-market approaches and resource allocation across major European markets.
- Healthcare Investors & PE Firms : Investment professionals require comprehensive market sizing and growth projections to evaluate European diabetes device companies and market opportunities. Regional analysis supports due diligence and portfolio strategy decisions.
- Healthcare Consultants & Advisors : Consultants advising healthcare organizations and device companies need authoritative European market data to support strategic recommendations. Country-level insights enable tailored advice for market expansion and competitive strategy.
- Pharmaceutical & Biotech Companies : Companies developing diabetes treatments and complementary devices need market context on device adoption rates and competitive landscape. European market data informs partnership and distribution strategy decisions.
- Healthcare Policy & Government Officials : Policymakers and health ministry officials require market intelligence to inform reimbursement policies, healthcare spending decisions, and digital health initiatives. Regional market data supports evidence-based healthcare planning.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 4763.8 Million |
| UK | USD 1727.1 Million |
| France | USD 2504 Million |
| Italy | USD 1888.8 Million |
| Spain | USD 1660.9 Million |
| Rest Of Europe | USD 5187 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Breakdown : Access detailed market sizing for Germany, France, Italy, UK, and Spain with individual valuations and growth projections. Understand regional variations in device adoption, reimbursement policies, and competitive dynamics across major European markets.
- Growth Opportunity Identification : Identify high-growth segments within Europe's 10.8% CAGR market. Pinpoint emerging opportunities in CGM systems, insulin delivery devices, and connected diabetes management solutions across different European healthcare systems.
- Competitive Landscape Intelligence : Understand market positioning of leading device manufacturers in Europe. Analyze competitive strategies, market share distribution, and differentiation approaches across major European markets and segments.
- Regulatory & Reimbursement Insights : Navigate Europe's complex regulatory environment with market-specific guidance on CE marking, reimbursement policies, and healthcare system requirements. Understand how different European countries approach diabetes device approval and coverage.
- Strategic Market Entry Planning : Develop data-driven market entry strategies for Europe with insights on market maturity, adoption rates, and growth potential by country. Identify optimal markets for product launches and expansion based on comprehensive regional analysis.
Frequently asked questions
What is the current size of Europe's diabetes care devices market?
Europe's diabetes care devices market was valued at $10,622.8 million in 2025 and is projected to reach $17,731.6 million by 2030.
What is the expected growth rate for diabetes care devices in Europe?
Europe's diabetes care devices market is expected to grow at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2030.
Which diabetes care devices are most in demand across Europe?
Continuous glucose monitoring (CGM) systems, insulin pumps, and connected diabetes management platforms are among the most in-demand devices in Europe due to improved accuracy and digital integration.
What factors are driving growth in Europe's diabetes care devices market?
Key drivers include an aging population, rising diabetes prevalence, improved reimbursement policies, strong healthcare infrastructure, and increasing adoption of digital health solutions across Europe.
How is Europe's regulatory environment affecting diabetes care device innovation?
Europe's robust regulatory frameworks, including CE marking and GDPR compliance, support innovation while ensuring patient safety, enabling manufacturers to bring advanced solutions to market efficiently.
RESEARCH METHODOLOGY
The study involved four main activities to estimate the current size of the diabetes care devices market. First, extensive secondary research was conducted to gather information about the market, including related and parent markets. The next step was validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Both top-down and bottom-up methods were used to develop a comprehensive estimate of the overall market size. Lastly, market segmentation and data triangulation techniques were employed to determine the sizes of segments and subsegments within the market.
Secondary Research
The secondary research process involved extensive use of various sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the diabetes care devices market. It also helped obtain critical insights about key industry players, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.
Primary Research
In the primary research process, we conducted interviews with various sources from both the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts, including CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations involved in the diabetes care devices market, were interviewed. For the demand side, engagement with industry experts, purchase and sales managers, doctors, and personnel from research organizations was done. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.
A breakdown of the primary respondents for the diabetes care devices market is provided below:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the diabetes care devices market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the diabetes care devices market was determined from annual presentations by leading companies and publicly available secondary data. The share of products and services within the overall diabetes care devices market was calculated using secondary data and verified by primary participants to arrive at the total market size. Primary participants also further validated the data numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each stage, the assumptions and approaches were verified with industry experts contacted during primary research. Due to limitations in the data from secondary research, revenue estimates for individual companies (covering the overall diabetes care devices market and geographic market assessment) were determined based on a detailed analysis of their product offerings, geographic reach or strength (whether direct or through distributors or suppliers), and the market shares of leading players in specific regions and countries.
Global Diabetes Care Devices Market Size: Bottom-up and Top-down Approach
Data Triangulation
After determining the overall size from the market size estimation process described above, the total market was divided into several segments and subsegments. The data triangulation and market breakdown procedures outlined below were applied, where appropriate, to complete the overall market analysis and obtain precise statistics for various segments. The data was triangulated by examining different factors and trends from both demand and supply perspectives. Additionally, the market size was validated using both the top-down and bottom-up approaches.
Market Definition
The diabetes care devices includes medical technologies and tools used for monitoring, managing, and treating diabetes. It features blood glucose monitoring systems (such as glucometers, continuous glucose monitors, test strips, and lancets), insulin delivery devices (including insulin pens, pumps, syringes, and automated delivery systems), and related accessories. These devices help track glucose accurately, deliver insulin effectively, and improve patient outcomes by enabling better disease control, reducing complications, and enhancing quality of life. The market serves patients, healthcare providers, and caregivers and is driven by technological innovations, the rising prevalence of diabetes, and increasing demand for connected, user-friendly solutions.
Stakeholders
- Diabetes Care Devices’ Manufacturing Companies
- Contract Manufacturers
- Distributors, Suppliers, and Channel Partners of Diabetes Care Devices
- Senior Management
- Finance Department
- Procurement Department
- Hospitals & Clinics
- E-commerce and Digital Platforms
- Retail Pharmacies and Supermarkets
- Academic & Research Institutes
- Trade Associations and Industry Bodies
- Regulatory Bodies and Government Agencies
- Business Research and Consulting Service Providers
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, segment, analyse, and forecast the global diabetes care devices market by product type, disease type, patient care settings, and region
- To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the diabetes care devices market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries
- To profile the key players in the diabetes care devices market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the diabetes care devices market
Get the Full Diabetes Care Devices Market Report
Full forecast, segment splits, and company analysis for all Diabetes Care Devices Market.
- Canada Diabetes Care Devices Market
- US Diabetes Care Devices Market
- Germany Diabetes Care Devices Market
- UK Diabetes Care Devices Market
- France Diabetes Care Devices Market
- Italy Diabetes Care Devices Market
- Spain Diabetes Care Devices Market
- China Diabetes Care Devices Market
- Japan Diabetes Care Devices Market
- India Diabetes Care Devices Market
- Australia Diabetes Care Devices Market
- South Korea Diabetes Care Devices Market
- Brazil Diabetes Care Devices Market
- Mexico Diabetes Care Devices Market
- GCC Countries Diabetes Care Devices Market
- Rest Of Europe Diabetes Care Devices Market
- Rest Of Asia Pacific Diabetes Care Devices Market
- Rest Of Latin America Diabetes Care Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
